A carregar...
Projeto de investigação
Sem título
Financiador
Autores
Publicações
The antitumor activity of a lead thioxanthone is associated with alterations in cholesterol localization
Publication . Lima, Raquel T.; Sousa, Diana; Gomes, Ana Sara; Mendes, Nuno; Matthiesen, Rune; Matthiesen, Rune; Pedro, Madalena; Marques, Franklim; Pinto, Madalena M.; Sousa, Emília; Helena Vasconcelos, M.; NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM); Centro de Estudos de Doenças Crónicas (CEDOC); MDPI - Multidisciplinary Digital Publishing Institute
The search for novel anticancer small molecules and strategies remains a challenge. Our previous studies have identified TXA1 (1-{[2-(diethylamino)ethyl]amino}-4-propoxy-9H-thioxanthen-9-one) as a hit compound, with in vitro antitumor potential by modulating autophagy and apoptosis in human tumor cell lines. In the present study, the mechanism of action and antitumor potential of the soluble salt of this molecule (TXA1.HCl) was further investigated using in vitro and mouse xenograft tumor models of NSCLC. Our results showed that TXA1.HCl affected steroid biosynthesis, increased RagD expression, and caused abnormal cellular cholesterol localization. In addition, TXA1.HCl treatment presented no toxicity to nude mice and significantly reduced the growth of human NSCLC cells xenografts in mice. Overall, this work provides new insights into the mechanism of action of TXA1, which may be relevant for the development of anticancer therapeutic strategies, which target cholesterol transport.
Unidades organizacionais
Descrição
Palavras-chave
Contribuidores
Financiadores
Entidade financiadora
Fundação para a Ciência e a Tecnologia
Programa de financiamento
COMPETE
Número da atribuição
PEst-C/SAU/LA0003/2013